Agreed. That is a much larger component of treating longer term viral infections like HIV, Hepatitis, etc.
There are also additional secondary endpoints that coukd make it very synergistic with existing treatments for COVID. There's still nothing great out there. Gilead may get a combo trial on the cheap with us now that we're weak.